Journal of Antimicrobial Chemotherapy (1995) 36, 253-258
© 1995 The British Society for Antimicrobial Chemotherapy
brief-report |
Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium
Department of Medicine (1 I IE), Department of Veterans Affairs Medical Center 800 Poly Place, Brooklyn, New York 11209, USA
Received 5 July 1994; returned 11 November 1994; accepted 13 February 1995
The combination of ampicillin and ciprofloxacin displayed bactericidal in-vitro activity against two strains of Enterococcus faecixan which were highly resistant to ampicillin, vancomycin, and aminoglycosides. This antibiotic combination wasused to treat rabbits with experimental endocarditis caused by these strains. Although a significant decrease in vegetation bacterial counts occurred with one strain, the degree of killing did not approach that of penicillin with an aminoglycoside against susceptible enterococci.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. E. Murray Vancomycin-Resistant Enterococcal Infections N. Engl. J. Med., March 9, 2000; 342(10): 710 - 721. [Full Text] [PDF] |
||||
![]() |
M. F. Tripodi, A. Rambaldi, G. Sarnataro, E. Ragone, and R. Utili The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium J. Antimicrob. Chemother., November 1, 1999; 44(5): 719 - 720. [Full Text] [PDF] |
||||
![]() |
S. O. Matsumura, L. Louie, M. Louie, and A. E. Simor Synergy Testing of Vancomycin-Resistant Enterococcus faecium against Quinupristin-Dalfopristin in Combination with Other Antimicrobial Agents Antimicrob. Agents Chemother., November 1, 1999; 43(11): 2776 - 2779. [Abstract] [Full Text] |
||||


